X
  • No products in the list

5-Gene-Multiplex Set cfDNA

Short description

The 5-Gene-Multiplex Set cfDNA is a powerful resource for oncology diagnostics and research, featuring critical genes: AKT1, BRAF, ERBB2, KRAS, and PIK3CA. This product is suitable for use as an allelic frequency standard in liquid biopsy assays, supporting applications in both clinical and research environments. It covers essential tumor types, including breast, colorectal, lung, melanoma, pancreatic, and ovarian carcinomas, among others.

Ideal for the development and validation of diagnostic kits, the 5-Gene-Multiplex Set cfDNA is crafted from highly characterized human cfDNA derived from cell lines. It offers allelic frequency standards at 0%, 0.1%, 1%, and 5%, enabling comprehensive qualitative and quantitative analysis. Comprising SID-000003, SID-000092, SID-000093, and SID-000094, this set provides the versatility needed for robust assay validation and internal process optimization.

For any laboratory or R&D department focused on liquid biopsy techniques, this product ensures high precision and reliability, driving advancements in cancer diagnostics and personalized treatment solutions.

Product highlights

  • Comprehensive Gene Coverage: Includes AKT1, BRAF, ERBB2, KRAS, and PIK3CA, addressing key mutations relevant to various cancers.
  • Reliable Standards: Provides 0%, 0.1%, 1%, and 5% allelic frequency standards, ensuring accurate and reproducible assay results.
  • High-Quality Material: Made from well-characterized human cfDNA, delivering robust performance for both qualitative and quantitative analyses.
  • Versatile Application: Suitable for diagnostics, assay validation, and R&D in liquid biopsy techniques, enhancing precision and efficiency.

Ask for a quote

5-Gene-Multiplex Set cfDNA

More
information

Specifications of the 5-Gene-Multiplex Set cfDNA

5-Gene-Multiplex Set cfDNA: An Essential Tool for Liquid Biopsy Assays

The 5-Gene-Multiplex Set cfDNA offers a highly valuable resource for both diagnostics and research in the field of oncology. Featuring five key genes—AKT1, BRAF, ERBB2, KRAS, and PIK3CA—this product is specifically designed to address the diagnostic and therapeutic challenges associated with various tumor types, such as:

  • Breast Carcinoma
  • Colorectal Carcinoma
  • Melanoma
  • Non-Small Cell Lung Carcinoma
  • Small Cell Lung Carcinoma
  • Prostate Carcinoma
  • Lymphoma
  • Head and Neck Carcinoma
  • Hepatocellular Carcinoma
  • Multiple Myeloma
  • Pancreatic Adenocarcinoma
  • Ovarian Carcinoma
  • Bladder Carcinoma
  • Bile Duct Carcinoma, among others.

The 5-Gene-Multiplex Set cfDNA can be employed as an allelic frequency (AF) standard in liquid biopsy assays within clinical laboratories or research and development (R&D) facilities. It is crucial for validating diagnostic kits and optimizing assay performance. The cfDNA used as background material is derived from well-characterized human cell lines, ensuring high reliability.

This set includes distinct allelic frequency levels—0%, 0.1%, 1%, and 5%—which provide a comprehensive standard for qualitative and quantitative analysis. It comprises individual products (SID-000003, SID-000092, SID-000093, and SID-000094), delivering the flexibility needed to fine-tune and authenticate internal diagnostic procedures.

Whether your focus is on validating liquid biopsy methodologies or developing innovative diagnostic tools, the 5-Gene-Multiplex Set cfDNA offers unparalleled support. Its robust design makes it an indispensable asset for researchers and clinical professionals aiming to advance precision medicine.

Components of the 5-Gene-Multiplex Set cfDNA
  •  5-Gene-Multiplex Set cfDNA

 

Explore Related Items